Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toripalimab”

443 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 443 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07392060
What this trial is testing

A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment

Who this might be right for
Cervical Cancer Metastatic
Shanghai Jiatan Pharmatech Co., Ltd 440
Testing effectiveness (Phase 2)Looking for participantsNCT07140679
What this trial is testing

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Who this might be right for
Localized Colon CarcinomaStage IIB Colon Cancer AJCC v8Stage IIC Colon Cancer AJCC v8+1 more
Emory University 40
Large-scale testing (Phase 3)Looking for participantsNCT06170489
What this trial is testing

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

Who this might be right for
Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd. 185
Testing effectiveness (Phase 2)Study completedNCT04169672
What this trial is testing

Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hutchison Medipharma Limited 248
Large-scale testing (Phase 3)Looking for participantsNCT04376866
What this trial is testing

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University 204
Early research (Phase 1)WithdrawnNCT05650203
What this trial is testing

JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

Who this might be right for
Primary Condition: Advanced Tumors
Shanghai Junshi Bioscience Co., Ltd.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363330
What this trial is testing

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

Who this might be right for
Cervical CancerRecurrentMetastatic
Zhongnan Hospital 32
Early research (Phase 1)Looking for participantsNCT07625423
What this trial is testing

Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors

Who this might be right for
Head & Neck CancerNasopharyngeal Cancinoma (NPC)
West China Hospital 9
Testing effectiveness (Phase 2)UnknownNCT05055583
What this trial is testing

Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC

Who this might be right for
NSCLC Stage IVOligometastasis
Tang-Du Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06611813
What this trial is testing

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

Who this might be right for
HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University 30
Large-scale testing (Phase 3)Looking for participantsNCT06201065
What this trial is testing

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Early research (Phase 1)Active Not RecruitingNCT05167071
What this trial is testing

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Who this might be right for
Solid TumorsNeuroendocrine TumorsCRC
Harbour BioMed (Guangzhou) Co. Ltd. 53
Testing effectiveness (Phase 2)UnknownNCT05420597
What this trial is testing

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

Who this might be right for
Laryngeal CancerHypopharyngeal Cancer
Fudan University 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06588335
What this trial is testing

BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05424432
What this trial is testing

Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus

Who this might be right for
Locally Advanced Esophageal Carcinoma
Jiangsu Cancer Institute & Hospital 63
Large-scale testing (Phase 3)Not Yet RecruitingNCT07332221
What this trial is testing

Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

Who this might be right for
Esophageal Cancer
Henan Cancer Hospital 435
Testing effectiveness (Phase 2)Active Not RecruitingNCT07380633
What this trial is testing

Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 90
Not applicableNot Yet RecruitingNCT07500831
What this trial is testing

Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellMetastatic Renal Cell CarcinomaAdvanced Renal Cell Carcinoma
Qilu Hospital of Shandong University 43
Testing effectiveness (Phase 2)UnknownNCT04006041
What this trial is testing

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma by AJCC V8 StageResectable Esophageal Cancer
Jianhua Fu 44
Testing effectiveness (Phase 2)Looking for participantsNCT06791070
What this trial is testing

RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum

Who this might be right for
Paget Disease, ExtramammaryScrotum Disease
Fujian Medical University Union Hospital 20
Load More Results